Frazier Life Sciences Management as of June 30, 2025
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 49 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | 13.8 | $346M | 6.8M | 50.89 | |
| Verona Pharma Sponsored Ads (VRNA) | 12.8 | $320M | 3.4M | 94.58 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 12.0 | $301M | 17M | 18.11 | |
| Bridgebio Pharma (BBIO) | 6.6 | $164M | 3.8M | 43.18 | |
| Arcutis Biotherapeutics (ARQT) | 5.5 | $138M | 9.9M | 14.02 | |
| Phathom Pharmaceuticals (PHAT) | 4.8 | $120M | 13M | 9.59 | |
| Krystal Biotech (KRYS) | 3.8 | $95M | 689k | 137.46 | |
| Disc Medicine (IRON) | 3.5 | $88M | 1.7M | 52.96 | |
| Mbx Biosciences (MBX) | 2.7 | $68M | 6.0M | 11.41 | |
| Tarsus Pharmaceuticals (TARS) | 2.3 | $57M | 1.4M | 40.51 | |
| Trevi Therapeutics (TRVI) | 2.2 | $56M | 10M | 5.47 | |
| Maze Therapeatics (MAZE) | 2.2 | $56M | 4.6M | 12.27 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $55M | 4.9M | 11.30 | |
| Zai Lab Adr (ZLAB) | 1.8 | $46M | 1.3M | 34.97 | |
| Agios Pharmaceuticals (AGIO) | 1.7 | $43M | 1.3M | 33.26 | |
| Revolution Medicines (RVMD) | 1.5 | $37M | 998k | 36.79 | |
| Ultragenyx Pharmaceutical (RARE) | 1.4 | $36M | 984k | 36.36 | |
| Aura Biosciences (AURA) | 1.3 | $32M | 5.1M | 6.26 | |
| Erasca (ERAS) | 1.2 | $29M | 23M | 1.27 | |
| Alkermes SHS (ALKS) | 1.1 | $29M | 1.0M | 28.61 | |
| Savara (SVRA) | 1.0 | $26M | 12M | 2.28 | |
| Mereo Biopharma Group Spon Ads (MREO) | 1.0 | $26M | 9.4M | 2.71 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $23M | 133k | 172.60 | |
| Evolus (EOLS) | 0.9 | $22M | 2.4M | 9.21 | |
| Hillevax | 0.8 | $21M | 11M | 1.99 | |
| Cg Oncology (CGON) | 0.8 | $20M | 770k | 26.00 | |
| Akero Therapeutics (AKRO) | 0.8 | $20M | 367k | 53.36 | |
| Cytokinetics Com New (CYTK) | 0.7 | $18M | 555k | 33.04 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $18M | 4.4M | 4.02 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $18M | 625k | 28.40 | |
| Jade Biosciences Com New (JBIO) | 0.7 | $18M | 1.8M | 9.99 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.7 | $16M | 722k | 22.54 | |
| Vaxcyte (PCVX) | 0.6 | $15M | 474k | 32.51 | |
| Travere Therapeutics (TVTX) | 0.6 | $15M | 1.0M | 14.80 | |
| Dyne Therapeutics (DYN) | 0.6 | $14M | 1.5M | 9.52 | |
| Cogent Biosciences (COGT) | 0.5 | $13M | 1.7M | 7.18 | |
| Immunocore Hldgs Ads (IMCR) | 0.5 | $12M | 385k | 31.38 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $11M | 1.1M | 10.15 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $11M | 4.6M | 2.28 | |
| Valneva Se Sponsored Ads (VALN) | 0.3 | $8.2M | 1.5M | 5.65 | |
| Crescent Biopharma (CBIO) | 0.3 | $7.3M | 454k | 16.14 | |
| Design Therapeutics (DSGN) | 0.3 | $6.6M | 2.0M | 3.37 | |
| Oruka Therapeutics (ORKA) | 0.3 | $6.5M | 583k | 11.21 | |
| Silence Therapeutics Ads (SLN) | 0.2 | $5.6M | 970k | 5.80 | |
| Allogene Therapeutics (ALLO) | 0.2 | $4.4M | 3.9M | 1.13 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.2 | $4.0M | 500k | 8.00 | |
| Macrogenics (MGNX) | 0.2 | $3.8M | 3.2M | 1.21 | |
| Adverum Biotechnologies Com New (ADVM) | 0.1 | $2.3M | 1.1M | 2.15 | |
| Elevation Oncology (ELEV) | 0.1 | $2.2M | 6.0M | 0.37 |
